Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 29, 2024
The Mucosal Protection in the Treatment of Erosive Reflux Esophagitis: Mechanisms for Restoring Epithelial Permeability. A Randomized Clinical Trial
Dmitry S Bordin, Maria A Livzan, Sergei I Mozgovoi, et al.
Diagnostics (Basel, Switzerland)
|
January 21, 2023
Diagnostic Principles for Chronic Gastritis Associated with Duodenogastric Reflux
Maria A Livzan, Sergei I Mozgovoi, Olga V Gaus, et al.
Diagnostics (Basel, Switzerland)
|
August 26, 2023
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned
Igor V Maev, Maria A Livzan, Sergei I Mozgovoi, et al.
Antibiotics (Basel, Switzerland)
|
June 26, 2026
Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)
Dmitry S Bordin, Dmitrii N Andreev, Sayar R Abdulkhakov, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 29, 2024
The Mucosal Protection in the Treatment of Erosive Reflux Esophagitis: Mechanisms for Restoring Epithelial Permeability. A Randomized Clinical Trial
Dmitry S Bordin, Maria A Livzan, Sergei I Mozgovoi, et al.
Diagnostics (Basel, Switzerland)
|
January 21, 2023
Diagnostic Principles for Chronic Gastritis Associated with Duodenogastric Reflux
Maria A Livzan, Sergei I Mozgovoi, Olga V Gaus, et al.
Diagnostics (Basel, Switzerland)
|
August 26, 2023
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned
Igor V Maev, Maria A Livzan, Sergei I Mozgovoi, et al.
Antibiotics (Basel, Switzerland)
|
June 26, 2026
Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)
Dmitry S Bordin, Dmitrii N Andreev, Sayar R Abdulkhakov, et al.
Page
of 3